Article
Molecular profiling for precision cancer therapies
14 Jan 2020
Abstract excerpt
The number of druggable tumor-specific molecular aberrations has grown substantially in the past decade, with a significant survival benefit obtained from biomarker matching therapies in several cancer types. Molecular pathology has therefore become fundamental not only to inform on tumor diagnosis and prognosis but also to drive therapeutic decisions in daily practice. The introduction of next-generation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
